L.A. van Walraven

431 total citations
14 papers, 168 citations indexed

About

L.A. van Walraven is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Internal Medicine. According to data from OpenAlex, L.A. van Walraven has authored 14 papers receiving a total of 168 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 12 papers in Pulmonary and Respiratory Medicine and 2 papers in Internal Medicine. Recurrent topics in L.A. van Walraven's work include Peripheral Artery Disease Management (12 papers), Vascular Procedures and Complications (11 papers) and Cerebrovascular and Carotid Artery Diseases (6 papers). L.A. van Walraven is often cited by papers focused on Peripheral Artery Disease Management (12 papers), Vascular Procedures and Complications (11 papers) and Cerebrovascular and Carotid Artery Diseases (6 papers). L.A. van Walraven collaborates with scholars based in Netherlands, Switzerland and Germany. L.A. van Walraven's co-authors include Michel M.P.J. Reijnen, Clark J. Zeebregts, Suzanne Holewijn, M.M. Lensvelt, W.M. Fritschy, O.R. Wikkeling, R.R. Kruse, L. Smeets, J. B. C. de Klerk and Wim C.J. Hop and has published in prestigious journals such as Journal of Vascular Surgery, Journal of Pediatric Surgery and JACC: Cardiovascular Interventions.

In The Last Decade

L.A. van Walraven

13 papers receiving 164 citations

Peers

L.A. van Walraven
Jean Deguara United Kingdom
Ernesto Rivera United States
Gaurav Aggarwala United States
Prakash Makam United States
Tommaso Donati United Kingdom
Andreas Luhmann United Kingdom
Jean Deguara United Kingdom
L.A. van Walraven
Citations per year, relative to L.A. van Walraven L.A. van Walraven (= 1×) peers Jean Deguara

Countries citing papers authored by L.A. van Walraven

Since Specialization
Citations

This map shows the geographic impact of L.A. van Walraven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.A. van Walraven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.A. van Walraven more than expected).

Fields of papers citing papers by L.A. van Walraven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L.A. van Walraven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.A. van Walraven. The network helps show where L.A. van Walraven may publish in the future.

Co-authorship network of co-authors of L.A. van Walraven

This figure shows the co-authorship network connecting the top 25 collaborators of L.A. van Walraven. A scholar is included among the top collaborators of L.A. van Walraven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L.A. van Walraven. L.A. van Walraven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Tielliu, Ignace F.J., et al.. (2025). Editor's Choice – Long Term Follow Up after Endovascular Popliteal Artery Aneurysm Repair: A Two Centre, Retrospective Cohort Study (1998 – 2023). European Journal of Vascular and Endovascular Surgery. 70(4). 483–489.
2.
Walraven, L.A. van, Michel Bosiers, Koen Deloose, et al.. (2024). Post hoc analysis of the SuperB and Zilverpass trials for treatment of long and complex superficial femoral artery lesions. Journal of Vascular Surgery. 80(2). 505–514.e2. 1 indexed citations
3.
Walraven, L.A. van, Suzanne Holewijn, W.M. Fritschy, et al.. (2024). Five-Year Outcomes of the SuperB Trial: A Multicenter Randomized Controlled Trial Comparing Heparin-Bonded Endograft to Surgical Femoropopliteal Bypass. Journal of Endovascular Therapy. 32(6). 2007–2019. 1 indexed citations
4.
Walraven, L.A. van, et al.. (2022). Endovascular bypass as a strategy for long femoropopliteal lesions. The Journal of Cardiovascular Surgery. 63(5). 562–574. 4 indexed citations
6.
Reijnen, Michel M.P.J., L.A. van Walraven, W.M. Fritschy, et al.. (2017). 1-Year Results of a Multicenter Randomized Controlled Trial Comparing Heparin-Bonded Endoluminal to Femoropopliteal Bypass. JACC: Cardiovascular Interventions. 10(22). 2320–2331. 47 indexed citations
7.
Kruse, R.R., et al.. (2015). Three-year outcome of the heparin-bonded Viabahn for superficial femoral artery occlusive disease. Journal of Vascular Surgery. 62(4). 984–989. 16 indexed citations
8.
Holewijn, Suzanne, et al.. (2015). Efficacy of treatment of edge stenosis of endografts inserted for superficial femoral artery stenotic disease. Catheterization and Cardiovascular Interventions. 86(3). 492–498. 11 indexed citations
9.
Lensvelt, M.M., W.M. Fritschy, Suzanne Holewijn, et al.. (2013). Outcome of Thrombolysis and Thrombectomy for Thrombosed Endografts Inserted in the Superficial Femoral Artery for Occlusive Disease. Journal of Endovascular Therapy. 20(6). 836–843. 15 indexed citations
10.
Lensvelt, M.M., R.R. Kruse, Suzanne Holewijn, et al.. (2012). The outcome of failed endografts inserted for superficial femoral artery occlusive disease. Journal of Vascular Surgery. 57(2). 415–420. 17 indexed citations
12.
Wijffels, N., et al.. (2007). Late Development of Pancreas Necrosis During Acute Pancreatitis. Pancreas. 34(2). 215–219. 12 indexed citations
13.
Walraven, L.A. van, et al.. (2003). Severe acute necrotizing pancreatitis associated with lipoprotein lipase deficiency in childhood. Journal of Pediatric Surgery. 38(9). 1407–1408. 10 indexed citations
14.
Walraven, L.A. van, et al.. (2000). The Use of Vascular Stents in the Treatment of Iliac Artery Occlusion. International Journal of Angiology. 9(4). 232–235. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026